Second eyes to develop neovascular age-related macular degeneration have fewer symptoms and better one-year visual outcomes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Second eyes to develop neovascular age-related macular degeneration have fewer symptoms and better one-year visual outcomes ; volume:23 ; number:1 ; day:7 ; month:7 ; year:2023 ; pages:1-7 ; date:12.2023
BMC ophthalmology ; 23, Heft 1 (7.7.2023), 1-7, 12.2023
- Creator
-
Akkan Aydoğmuş, F. Sema
Onwuka, Oluchukwu
Saddemi, Jackson
Lasalle, Claudia C.
Ramsey, David J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-023-03021-0
- URN
-
urn:nbn:de:101:1-2023101110253663836028
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Akkan Aydoğmuş, F. Sema
- Onwuka, Oluchukwu
- Saddemi, Jackson
- Lasalle, Claudia C.
- Ramsey, David J.
- SpringerLink (Online service)
Other Objects (12)
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
One-year outcome of brolucizumab for neovascular age-related macular degeneration in Japanese patients
One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
Efficacy and Durability of Faricimab in Naïve Eyes with Neovascular Age-Related Macular Degeneration
Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Posterior Vitreous Detachment and Risk of Neovascular Glaucoma in Eyes with Prior Retinal Vascular Occlusions
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration
Fewer Ordnung
Fewer-Ordnung.
Fewer-Spiegel
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
One-year outcome of brolucizumab for neovascular age-related macular degeneration in Japanese patients
One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
Efficacy and Durability of Faricimab in Naïve Eyes with Neovascular Age-Related Macular Degeneration
Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Posterior Vitreous Detachment and Risk of Neovascular Glaucoma in Eyes with Prior Retinal Vascular Occlusions
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration
Fewer Ordnung
Fewer-Ordnung.
Fewer-Spiegel
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
One-year outcome of brolucizumab for neovascular age-related macular degeneration in Japanese patients
One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
Efficacy and Durability of Faricimab in Naïve Eyes with Neovascular Age-Related Macular Degeneration
Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Posterior Vitreous Detachment and Risk of Neovascular Glaucoma in Eyes with Prior Retinal Vascular Occlusions
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration
Fewer Ordnung
Fewer-Ordnung.